Artemis Medicare Services Ltd

Artemis Medicare Services Ltd., the Gurugram-based multi-speciality hospital operator, reported a robust 30.40% year-on-year surge in consolidated net profit to ₹30.03 crores for Q4 FY26, marking its strongest quarterly performance to date. The ₹4,149 crore market capitalisation company delivered revenue of ₹279.23 crores for the March quarter, up 16.39% YoY, as patient volumes and average revenue per occupied bed continued their upward trajectory.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for this small-cap hospital sector stock.

Artemis Medicare Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 5 May 2026, comes amid a backdrop of positive quarterly results, healthy debt servicing ability, and a stabilising technical outlook, signalling a cautious but optimistic stance for investors.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors in the hospital sector.

Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of its performance and outlook.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest 2.08% gain on 23 Apr 2026, the stock’s technical indicators reveal a cautious outlook, prompting a downgrade in its Mojo Grade from Hold to Sell as of 2 Mar 2026.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has seen a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest price change on 22 Apr 2026, the stock’s technical indicators signal caution for investors amid a challenging market backdrop and underwhelming relative returns compared to the Sensex.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day gain of 0.13%, the stock’s technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these developments in detail, placing them in the context of the company’s recent price performance and broader market trends.

Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Artemis Medicare Services Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend across multiple timeframes. The stock’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects deteriorating market sentiment amid weakening momentum and subdued relative strength, raising concerns for investors in this small-cap hospital sector player.

Despite a broadly positive market environment, Artemis Medicare Services Ltd has plunged to a fresh 52-week low of Rs 202.85 on 13 Apr 2026, marking a significant divergence from the broader indices and signalling persistent headwinds for the hospital sector small-cap.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance. Despite a modest day gain of 1.18%, the stock’s technical indicators reveal a complex picture of cautious investor sentiment and mixed signals across weekly and monthly timeframes.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting challenges in sustaining upward price momentum amid broader market fluctuations.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance. Despite a modest 2.40% gain in the latest session, key technical indicators such as MACD, RSI, and moving averages suggest cautious sentiment among investors, reflecting a complex interplay of short-term resilience and longer-term headwinds.

Artemis Medicare Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 05 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

The Sensex advanced 2.49% on 1 Apr 2026, yet Artemis Medicare Services Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 221.05. This 5.7-percentage-point outperformance over its Hospital sector peers highlights a distinctly stock-specific rally rather than a mere market tailwind.